サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1726309

腸疾患検査の世界市場：市場規模・シェア・動向分析 (疾患別・地域別)、セグメント別予測 (2025年～2030年)

Enteric Disease Testing Market Size, Share, & Trends Analysis Report By Disease (Bacterial, Viral, Parasitic), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.36円
腸疾患検査の世界市場：市場規模・シェア・動向分析 (疾患別・地域別)、セグメント別予測 (2025年～2030年)
出版日: 2025年04月21日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

腸疾患検査市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の腸疾患検査の市場規模は2030年までに47億4,000万米ドルに達すると予測され、2025年から2030年にかけてCAGR 3.1％で拡大すると予測されています。

腸疾患の罹患率の増加と高度な診断技術の採用の増加が市場成長の主な要因です。米国疾病管理予防センターによると、腸チフスの症例は世界中で毎年1,100万件近くと2,100万件、パラチフスの症例は約500万件記録されています。

ライフスタイルや消費者の嗜好の変化により、複数の地域で消化器感染症の発生率が増加しているため、腸疾患検査ソリューションに対する需要が高まっています。腸疾患は適切な時期に介入しなければ深刻な影響を及ぼすという認識が高まり、検査件数が増加しています。複数の政府機関が公衆衛生の保護とアウトブレイクの防止に注力していることも、今後数年間のこの業界の成長を促進すると予想されます。

検診プログラム、啓発キャンペーン、特定の福祉制度など、医療改善のための政府の取り組みは、市場の成長を促進すると予測されています。例えば米国では、疾病対策予防センター（CDC）が腸管疾患対応・調査・調整システム（SEDRIC）を使用して、食品や動物との接触に関連した疾病発生に対する効率的な監視と対応を行っています。また、BEAM（細菌、腸内細菌、アメーバ、真菌）ダッシュボードの管理にも役立っており、腸疾患発生データを一般の閲覧者に提供しています。このような取り組みにより、予測期間中の検査件数の増加が期待されます。

腸疾患検査市場：分析概要

  • 細菌性セグメントは、一般的な腸疾患の原因となる大腸菌、大腸炎菌、赤痢菌、サルモネラ菌などの多くの細菌により、2024年の腸疾患検査市場の約60%のシェアを占めました。
  • 寄生虫分野は、汚染された水や食品、様々な地域における劣悪な衛生システム、適切な衛生状態の欠如によって引き起こされる腸疾患の症例が増加しているため、成長が見込まれています。
  • 大規模な感染拡大を防ぐための高度な診断技術を特徴とする、改善された医療サービスを提供することに、複数の政府が重点を置くようになっていることが、成長機会を生み出すと予想されます。
  • 北米は、強固な医療インフラ、主要な診断技術開発企業やバイオテクノロジー企業の存在などの要因から、2024年には世界の業界を支配しました。
  • 地域機関による予防対策と政府出資の研究プログラムが成長を促進すると予想されます。
  • 2025年2月、BIOMERIEUX社は、同社の新しい検査ソリューションであるBIOFIRE FILMARRAY Gastrointestinal（GI）Panel Mid.が米国FDAから認可を受けたと発表しました。

目次

第1章 分析方法・範囲

第2章 エグゼクティブサマリー

第3章 腸疾患検査市場：変動要因・傾向・範囲

  • 市場連関の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因の分析
  • 腸疾患検査市場：分析ツール
    • 業界分析：ポーターのファイブフォース分析
    • PESTEL分析

第4章 腸疾患検査市場：疾患別の推定・動向分析

  • 疾患別のダッシュボード
  • 腸疾患検査市場：業界動向の分析
  • 世界の腸疾患検査市場：市場規模と動向分析：疾患別（2018～2030年）
  • 細菌性
    • 市場推計・予測（2018～2030年）
    • C.ディフィシル
    • カンピロバクター症
    • コレラ
    • 大腸菌
    • H.ピロリ菌
    • サルモネラ症
    • 細菌性赤痢
  • ウイルス
    • 市場推計・予測（2018～2030年）
    • ロタウイルス
    • ノロウイルス
  • 寄生虫
    • 市場推計・予測（2018～2030年）
    • アメーバ症
    • クリプトスポリジウム症
    • ジアルジア症

第5章 腸疾患検査市場：地域別の推定・動向分析

  • 市場ダッシュボード：地域別
  • 市場シェア分析：地域別（2024年・2030年）
  • 腸疾患検査市場：主なポイント、地域別
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • ラテンアメリカ
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 最近の動向と影響分析：主要市場参入企業別
  • 企業/競合の分類
  • ベンダー情勢
    • 主要企業のヒートマップ分析（2024年）
  • 企業プロファイル
    • Abbott
    • BD
    • Biomerica
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • Cepheid
    • Coris Bioconcept
    • DiaSorin SpA
    • Meridian Bioscience
    • Quest Diagnostics Incorporated
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 3 North America enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 4 U.S. enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 5 Canada enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 6 Mexico enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 7 Europe enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 8 Europe enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 9 UK enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 10 Germany enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 11 France enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 12 Italy enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 13 Spain enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 14 Denmark enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 15 Sweden enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 16 Norway enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 18 Asia Pacific enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 19 China enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 20 Japan enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 21 India enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 22 Australia enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 23 South Korea enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 24 Thailand enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 25 Latin America enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 26 Latin America enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 27 Brazil enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 28 Argentina enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 29 Middle East & Africa enteric disease testing market, by country, 2018 - 2030 (USD Million)
  • Table 30 Middle East & Africa enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 31 South Africa enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 33 UAE enteric disease testing market, by disease, 2018 - 2030 (USD Million)
  • Table 34 Kuwait enteric disease testing market, by disease, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Enteric disease testing market: market outlook
  • Fig. 10 Enteric disease competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 Enteric disease testing market driver impact
  • Fig. 16 Enteric disease testing market restraint impact
  • Fig. 17 Enteric disease testing market strategic initiatives analysis
  • Fig. 18 Global enteric disease testing market: Disease movement analysis
  • Fig. 19 Global enteric disease testing market: Disease outlook and key takeaways
  • Fig. 20 Bacterial enteric disease testing market estimates and forecast, 2018 - 2030
  • Fig. 21 Viral enteric disease testing market estimates and forecast, 2018 - 2030
  • Fig. 22 Rotavirus testing market estimates and forecast, 2018 - 2030
  • Fig. 23 Norovirus testing market estimates and forecast, 2018 - 2030
  • Fig. 24 Parasitic enteric disease testing market estimates and forecast, 2018-203
  • Fig. 25 Global enteric disease testing market: Regional movement analysis
  • Fig. 26 Global enteric disease testing market: Regional outlook and key takeaways
  • Fig. 27 North America enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 28 U.S. enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 29 Canada enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 30 Mexico enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 31 Europe enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 32 UK enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 33 Germany enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 34 France enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 35 Italy enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spain enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 37 Denmark enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 38 Sweden enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 39 Norway enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 41 China enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 42 Japan enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 43 India enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 44 Thailand enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 45 South Korea enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 46 Australia enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 47 Latin America enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 48 Brazil enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 49 Argentina enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 50 Middle East and Africa enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 51 South Africa enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 52 Saudi Arabia enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 53 UAE enteric disease testing market estimates and forecasts, 2018 - 2030
  • Fig. 54 Kuwait enteric disease testing market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-1-68038-542-7

Enteric Disease Testing Market Growth & Trends:

The global enteric disease testing market size is anticipated to reach USD 4.74 billion by 2030 and is anticipated to expand at a CAGR of 3.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing incidence of enteric diseases and the rising adoption of advanced diagnostic technologies are the major factors contributing to market growth. According to the U.S. Center for Disease Control and Prevention, nearly 11 and 21 million cases of typhoid fever and approximately 5 million paratyphoid fever cases are recorded worldwide each year.

The increasing incidence of gastrointestinal infections in multiple regions, driven by changing lifestyles and consumer preferences, has generated greater demand for enteric disease testing solutions. Growing awareness regarding the severe effects of enteric diseases, if not intervened in time, has led to the rising number of tests. The focus of multiple government agencies on protecting public health and preventing outbreaks is also expected to drive the growth of this industry in the coming years.

Government initiatives for improved healthcare, including screening programs, awareness campaigns, and specific welfare schemes, are projected to fuel market growth. For instance, in the U.S., the Centers for Disease Control and Prevention (CDC) uses the System for Enteric Disease Response, Investigation, and Coordination (SEDRIC) to ensure efficient surveillance and response to disease outbreaks linked to food or animal contact. It also helps manage the BEAM (Bacteria, Enterics, Ameba, and Mycotics) Dashboard, which provides enteric disease outbreak data to public viewers. Such initiatives are expected to result in increased testing in the forecast period.

Enteric Disease Testing Market Report Highlights:

  • The bacterial segment dominated the enteric disease testing market with nearly 60% share in 2024 owing to many bacteria, such as C. difficile, E. coli, Shigella, and Salmonella, which cause common enteric diseases.
  • The parasitic segment is expected to experience growth due to increasing cases of enteric diseases driven by contaminated water and food, poor sanitation systems in various regions, and lack of adequate hygiene.
  • The growing focus of multiple governments on offering improved healthcare services that feature advanced diagnostic technologies to prevent large-scale outbreaks is expected to create growth opportunities.
  • North America dominated the global industry in 2024 owing to factors such as a robust healthcare infrastructure and the presence of key diagnostic technology developers and biotechnology companies.
  • Preventive measures embraced by local agencies and government-funded research programs are anticipated to fuel growth.
  • In February 2025, BIOMERIEUX announced that it received clearance from the U.S. FDA for its new testing solution, BIOFIRE FILMARRAY Gastrointestinal (GI) Panel Mid.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Disease Outlook
    • 1.2.2. Regional Scope
    • 1.2.3. Estimates and Forecasts Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Disease Outlook
    • 2.2.2. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Enteric Diseases Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. Enteric Diseases Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis

Chapter 4. Enteric Diseases Testing: Disease Estimates & Trend Analysis

  • 4.1. Disease Segment Dashboard
  • 4.2. Enteric Diseases Testing Market: Industry Movement Analysis
  • 4.3. Global Enteric Diseases Testing Market Size & Trend Analysis, by Disease , 2018 to 2030 (USD Million)
  • 4.4. Bacterial
    • 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. C. Difficile
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Campylobacteriosis
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Cholera
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.5. E. Coli
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.6. H. Pylori
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.7. Salmonellosis
      • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.8. Shigellosis
      • 4.4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Viral
    • 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.2. Rotavirus
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.5.3. Norovirus
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Parasitic
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.2. Amebiasis
      • 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.3. Cryptosporidiosis
      • 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.6.4. Giardiasis
      • 4.6.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Enteric Diseases Testing Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Dashboard
  • 5.2. Regional Market Share Analysis, 2024 & 2030
  • 5.3. Continuous bioprocessing market by Region: Key Takeaways
  • 5.4. North America
    • 5.4.1. U.S.
      • 5.4.1.1. Key country dynamics
      • 5.4.1.2. Regulatory framework/ reimbursement structure
      • 5.4.1.3. Competitive scenario
      • 5.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Canada
      • 5.4.2.1. Key country dynamics
      • 5.4.2.2. Regulatory framework/ reimbursement structure
      • 5.4.2.3. Competitive scenario
      • 5.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Mexico
      • 5.4.3.1. Key country dynamics
      • 5.4.3.2. Regulatory framework/ reimbursement structure
      • 5.4.3.3. Competitive scenario
      • 5.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. UK
      • 5.5.1.1. Key country dynamics
      • 5.5.1.2. Regulatory framework/ reimbursement structure
      • 5.5.1.3. Competitive scenario
      • 5.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.2. Germany
      • 5.5.2.1. Key country dynamics
      • 5.5.2.2. Regulatory framework/ reimbursement structure
      • 5.5.2.3. Competitive scenario
      • 5.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.3. France
      • 5.5.3.1. Key country dynamics
      • 5.5.3.2. Regulatory framework/ reimbursement structure
      • 5.5.3.3. Competitive scenario
      • 5.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.4. Italy
      • 5.5.4.1. Key country dynamics
      • 5.5.4.2. Regulatory framework/ reimbursement structure
      • 5.5.4.3. Competitive scenario
      • 5.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.5. Spain
      • 5.5.5.1. Key country dynamics
      • 5.5.5.2. Regulatory framework/ reimbursement structure
      • 5.5.5.3. Competitive scenario
      • 5.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.6. Norway
      • 5.5.6.1. Key country dynamics
      • 5.5.6.2. Regulatory framework/ reimbursement structure
      • 5.5.6.3. Competitive scenario
      • 5.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.7. Sweden
      • 5.5.7.1. Key country dynamics
      • 5.5.7.2. Regulatory framework/ reimbursement structure
      • 5.5.7.3. Competitive scenario
      • 5.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.5.8. Denmark
      • 5.5.8.1. Key country dynamics
      • 5.5.8.2. Regulatory framework/ reimbursement structure
      • 5.5.8.3. Competitive scenario
      • 5.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Japan
      • 5.6.1.1. Key country dynamics
      • 5.6.1.2. Regulatory framework/ reimbursement structure
      • 5.6.1.3. Competitive scenario
      • 5.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.2. China
      • 5.6.2.1. Key country dynamics
      • 5.6.2.2. Regulatory framework/ reimbursement structure
      • 5.6.2.3. Competitive scenario
      • 5.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.3. India
      • 5.6.3.1. Key country dynamics
      • 5.6.3.2. Regulatory framework/ reimbursement structure
      • 5.6.3.3. Competitive scenario
      • 5.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.4. Australia
      • 5.6.4.1. Key country dynamics
      • 5.6.4.2. Regulatory framework/ reimbursement structure
      • 5.6.4.3. Competitive scenario
      • 5.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key country dynamics
      • 5.6.5.2. Regulatory framework/ reimbursement structure
      • 5.6.5.3. Competitive scenario
      • 5.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.6.6. Thailand
      • 5.6.6.1. Key country dynamics
      • 5.6.6.2. Regulatory framework/ reimbursement structure
      • 5.6.6.3. Competitive scenario
      • 5.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Brazil
      • 5.7.1.1. Key country dynamics
      • 5.7.1.2. Regulatory framework/ reimbursement structure
      • 5.7.1.3. Competitive scenario
      • 5.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.7.2. Argentina
      • 5.7.2.1. Key country dynamics
      • 5.7.2.2. Regulatory framework/ reimbursement structure
      • 5.7.2.3. Competitive scenario
      • 5.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. South Africa
      • 5.8.1.1. Key country dynamics
      • 5.8.1.2. Regulatory framework/ reimbursement structure
      • 5.8.1.3. Competitive scenario
      • 5.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.2. Saudi Arabia
      • 5.8.2.1. Key country dynamics
      • 5.8.2.2. Regulatory framework/ reimbursement structure
      • 5.8.2.3. Competitive scenario
      • 5.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.3. UAE
      • 5.8.3.1. Key country dynamics
      • 5.8.3.2. Regulatory framework/ reimbursement structure
      • 5.8.3.3. Competitive scenario
      • 5.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.8.4. Kuwait
      • 5.8.4.1. Key country dynamics
      • 5.8.4.2. Regulatory framework/ reimbursement structure
      • 5.8.4.3. Competitive scenario
      • 5.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
  • 6.3. Vendor Landscape
    • 6.3.1. Key company heat map analysis, 2024
  • 6.4. Company Profiles
    • 6.4.1. Abbott
      • 6.4.1.1. Company overview
      • 6.4.1.2. Financial performance
      • 6.4.1.3. Product benchmarking
      • 6.4.1.4. Strategic initiatives
    • 6.4.2. BD
      • 6.4.2.1. Company overview
      • 6.4.2.2. Financial performance
      • 6.4.2.3. Product benchmarking
      • 6.4.2.4. Strategic initiatives
    • 6.4.3. Biomerica
      • 6.4.3.1. Company overview
      • 6.4.3.2. Financial performance
      • 6.4.3.3. Product benchmarking
      • 6.4.3.4. Strategic initiatives
    • 6.4.4. BIOMERIEUX
      • 6.4.4.1. Company overview
      • 6.4.4.2. Financial performance
      • 6.4.4.3. Product benchmarking
      • 6.4.4.4. Strategic initiatives
    • 6.4.5. Bio-Rad Laboratories, Inc.
      • 6.4.5.1. Company overview
      • 6.4.5.2. Financial performance
      • 6.4.5.3. Product benchmarking
      • 6.4.5.4. Strategic initiatives
    • 6.4.6. Cepheid
      • 6.4.6.1. Company overview
      • 6.4.6.2. Financial performance
      • 6.4.6.3. Product benchmarking
      • 6.4.6.4. Strategic initiatives
    • 6.4.7. Coris Bioconcept
      • 6.4.7.1. Company overview
      • 6.4.7.2. Financial performance
      • 6.4.7.3. Product benchmarking
      • 6.4.7.4. Strategic initiatives
    • 6.4.8. DiaSorin S.p.A.
      • 6.4.8.1. Company overview
      • 6.4.8.2. Financial performance
      • 6.4.8.3. Product benchmarking
      • 6.4.8.4. Strategic initiatives
    • 6.4.9. Meridian Bioscience
      • 6.4.9.1. Company overview
      • 6.4.9.2. Financial performance
      • 6.4.9.3. Product benchmarking
      • 6.4.9.4. Strategic initiatives
    • 6.4.10. Quest Diagnostics Incorporated
      • 6.4.10.1. Company overview
      • 6.4.10.2. Financial performance
      • 6.4.10.3. Product benchmarking
      • 6.4.10.4. Strategic initiatives